KRAS and central nervous system cancer: Primary glioblastomas (GBMs) are often associated with disturbed RAS signaling, although mutations in KRAS gene are rare in human gliomas and particularly rare in WHO grade III and IV gliomas in adult patients [21, 26, 32, 40].